| 000 | 01439 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513204239.0 | ||
| 264 | 0 | _c20000515 | |
| 008 | 200005s 0 0 eng d | ||
| 022 | _a0300-0664 | ||
| 024 | 7 |
_a10.1046/j.1365-2265.2000.00964.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDavies, J S | |
| 245 | 0 | 0 |
_aA therapeutic trial of growth hormone in hypopituitary adults and its influence upon continued prescription by general practitioners. _h[electronic resource] |
| 260 |
_bClinical endocrinology _cMar 2000 |
||
| 300 |
_a295-303 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGrowth Hormone _xblood |
| 650 | 0 | 4 |
_aHuman Growth Hormone _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypopituitarism _xblood |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xanalysis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRefusal to Treat |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aTreatment Refusal |
| 700 | 1 | _aObuobie, K | |
| 700 | 1 | _aSmith, J | |
| 700 | 1 | _aRees, D A | |
| 700 | 1 | _aFurlong, A | |
| 700 | 1 | _aDavies, N | |
| 700 | 1 | _aEvans, L M | |
| 700 | 1 | _aScanlon, M F | |
| 773 | 0 |
_tClinical endocrinology _gvol. 52 _gno. 3 _gp. 295-303 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2265.2000.00964.x _zAvailable from publisher's website |
| 999 |
_c10672703 _d10672703 |
||